,CGDHCT

Jennifer W Leiding1,2, Danielle E Arnold3, Suhag Parikh4

  • 1Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD.

Blood
|August 10, 2023
PubMed
概括

血造细胞移植 (HCT) 提供了慢性颗粒状细胞疾病 (CGD) 的最终治疗方法,从而改善健康和减少疾病负担. 建议在早期进行HCT,即使有活跃的感染或炎症,以防止并发症.